Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Muscle, Skeletal | 25 | 2024 | 468 | 5.200 |
Why?
|
Muscular Dystrophy, Duchenne | 10 | 2024 | 34 | 3.110 |
Why?
|
Annexin A6 | 6 | 2022 | 10 | 2.260 |
Why?
|
Muscular Dystrophies | 7 | 2024 | 55 | 2.130 |
Why?
|
Muscle Proteins | 8 | 2021 | 133 | 2.110 |
Why?
|
Cell Membrane | 9 | 2021 | 670 | 2.010 |
Why?
|
Membrane Proteins | 11 | 2021 | 1216 | 1.970 |
Why?
|
Muscular Dystrophy, Animal | 8 | 2019 | 21 | 1.870 |
Why?
|
Muscle Fibers, Skeletal | 6 | 2019 | 49 | 1.810 |
Why?
|
Immunoglobulin G | 6 | 2023 | 465 | 1.760 |
Why?
|
Muscular Dystrophies, Limb-Girdle | 6 | 2024 | 15 | 1.480 |
Why?
|
Dysferlin | 6 | 2024 | 14 | 1.390 |
Why?
|
Calcium | 4 | 2022 | 1174 | 1.200 |
Why?
|
Mice, Inbred mdx | 5 | 2024 | 13 | 1.180 |
Why?
|
Muscle Development | 6 | 2019 | 41 | 1.150 |
Why?
|
Dried Blood Spot Testing | 3 | 2021 | 10 | 1.120 |
Why?
|
Vesicular Transport Proteins | 3 | 2015 | 63 | 1.050 |
Why?
|
Muscles | 3 | 2024 | 193 | 1.000 |
Why?
|
Disease Models, Animal | 8 | 2024 | 2363 | 0.990 |
Why?
|
Vaccines, Synthetic | 2 | 2021 | 55 | 0.970 |
Why?
|
Mice | 27 | 2024 | 11743 | 0.880 |
Why?
|
Myoblasts | 7 | 2024 | 32 | 0.840 |
Why?
|
Sarcolemma | 10 | 2019 | 31 | 0.830 |
Why?
|
Sarcoglycans | 7 | 2024 | 14 | 0.820 |
Why?
|
Animals | 36 | 2024 | 27338 | 0.810 |
Why?
|
Membrane Fusion | 3 | 2021 | 37 | 0.810 |
Why?
|
Neuromuscular Diseases | 1 | 2021 | 31 | 0.790 |
Why?
|
Excitation Contraction Coupling | 1 | 2021 | 8 | 0.780 |
Why?
|
Myocytes, Cardiac | 8 | 2024 | 313 | 0.780 |
Why?
|
Biomarkers | 3 | 2024 | 1764 | 0.780 |
Why?
|
Family Characteristics | 2 | 2022 | 48 | 0.770 |
Why?
|
Serologic Tests | 2 | 2021 | 43 | 0.770 |
Why?
|
Annexins | 2 | 2022 | 6 | 0.760 |
Why?
|
Induced Pluripotent Stem Cells | 5 | 2024 | 116 | 0.720 |
Why?
|
Pandemics | 5 | 2023 | 771 | 0.710 |
Why?
|
Insulin-Like Growth Factor I | 2 | 2010 | 114 | 0.680 |
Why?
|
Gene Editing | 1 | 2019 | 48 | 0.670 |
Why?
|
Exons | 3 | 2019 | 451 | 0.670 |
Why?
|
Spike Glycoprotein, Coronavirus | 5 | 2022 | 43 | 0.660 |
Why?
|
Antibodies, Viral | 6 | 2022 | 309 | 0.630 |
Why?
|
Health Personnel | 1 | 2020 | 215 | 0.610 |
Why?
|
Muscle Cells | 1 | 2017 | 18 | 0.580 |
Why?
|
Betacoronavirus | 1 | 2020 | 261 | 0.580 |
Why?
|
Prednisone | 4 | 2024 | 259 | 0.570 |
Why?
|
Protein Transport | 8 | 2016 | 421 | 0.560 |
Why?
|
Health | 1 | 2015 | 29 | 0.520 |
Why?
|
Pneumonia, Viral | 1 | 2020 | 319 | 0.500 |
Why?
|
Coronavirus Infections | 1 | 2020 | 304 | 0.500 |
Why?
|
Disease | 1 | 2015 | 90 | 0.490 |
Why?
|
Neutralization Tests | 4 | 2022 | 80 | 0.490 |
Why?
|
Glucocorticoids | 5 | 2024 | 358 | 0.490 |
Why?
|
Muscular Diseases | 3 | 2023 | 64 | 0.470 |
Why?
|
Dynamin II | 1 | 2014 | 15 | 0.470 |
Why?
|
Myopathies, Structural, Congenital | 1 | 2014 | 10 | 0.470 |
Why?
|
Quadriceps Muscle | 1 | 2014 | 5 | 0.470 |
Why?
|
Proteostasis | 2 | 2024 | 12 | 0.470 |
Why?
|
Glycerol | 1 | 2013 | 35 | 0.450 |
Why?
|
Male | 19 | 2024 | 42347 | 0.440 |
Why?
|
Magnetic Resonance Imaging | 2 | 2024 | 3444 | 0.430 |
Why?
|
Actins | 1 | 2016 | 458 | 0.430 |
Why?
|
Antibodies, Neutralizing | 3 | 2022 | 120 | 0.420 |
Why?
|
Fibrosis | 4 | 2023 | 234 | 0.410 |
Why?
|
Mice, Knockout | 6 | 2024 | 1990 | 0.410 |
Why?
|
Gene Expression | 3 | 2019 | 1310 | 0.390 |
Why?
|
Antibody Formation | 2 | 2021 | 171 | 0.380 |
Why?
|
Seroepidemiologic Studies | 2 | 2021 | 53 | 0.370 |
Why?
|
RNA, Messenger | 3 | 2019 | 2012 | 0.370 |
Why?
|
Mice, 129 Strain | 3 | 2021 | 56 | 0.370 |
Why?
|
NFATC Transcription Factors | 1 | 2010 | 49 | 0.360 |
Why?
|
Latent TGF-beta Binding Proteins | 2 | 2021 | 4 | 0.350 |
Why?
|
Receptor, IGF Type 1 | 1 | 2009 | 45 | 0.350 |
Why?
|
DNA | 1 | 2015 | 1307 | 0.350 |
Why?
|
Wound Healing | 4 | 2016 | 359 | 0.340 |
Why?
|
Female | 15 | 2024 | 46118 | 0.330 |
Why?
|
Mice, Inbred C57BL | 6 | 2024 | 3211 | 0.320 |
Why?
|
Humans | 29 | 2024 | 89222 | 0.320 |
Why?
|
Extracellular Matrix | 3 | 2024 | 244 | 0.310 |
Why?
|
Young Adult | 5 | 2024 | 6301 | 0.290 |
Why?
|
Carrier Proteins | 3 | 2021 | 681 | 0.280 |
Why?
|
Vaccination | 3 | 2023 | 274 | 0.250 |
Why?
|
Cells, Cultured | 6 | 2018 | 2880 | 0.250 |
Why?
|
Regeneration | 3 | 2017 | 150 | 0.250 |
Why?
|
Middle Aged | 7 | 2024 | 25929 | 0.240 |
Why?
|
Adult | 7 | 2024 | 26559 | 0.240 |
Why?
|
Immunoblotting | 2 | 2016 | 273 | 0.240 |
Why?
|
Filamins | 1 | 2024 | 22 | 0.240 |
Why?
|
Cardiomyopathies | 2 | 2024 | 264 | 0.240 |
Why?
|
Proto-Oncogene Proteins c-bcl-6 | 1 | 2024 | 44 | 0.230 |
Why?
|
Myocarditis | 1 | 2024 | 51 | 0.230 |
Why?
|
Mice, Inbred DBA | 6 | 2024 | 149 | 0.220 |
Why?
|
Mice, Mutant Strains | 2 | 2016 | 231 | 0.220 |
Why?
|
Adaptor Proteins, Signal Transducing | 2 | 2015 | 313 | 0.210 |
Why?
|
Tumor Suppressor Proteins | 2 | 2015 | 290 | 0.210 |
Why?
|
Tissue Engineering | 1 | 2024 | 185 | 0.210 |
Why?
|
Mice, Transgenic | 4 | 2022 | 1574 | 0.210 |
Why?
|
Calcium-Binding Proteins | 2 | 2021 | 121 | 0.200 |
Why?
|
Immunologic Tests | 1 | 2021 | 6 | 0.200 |
Why?
|
Monocytes | 1 | 2023 | 218 | 0.200 |
Why?
|
Nerve Tissue Proteins | 2 | 2015 | 511 | 0.200 |
Why?
|
Drug Interactions | 1 | 2021 | 245 | 0.190 |
Why?
|
Extracellular Vesicles | 1 | 2022 | 42 | 0.190 |
Why?
|
Heart Diseases | 1 | 2023 | 298 | 0.190 |
Why?
|
Cell Differentiation | 2 | 2024 | 1521 | 0.180 |
Why?
|
Steroids | 1 | 2021 | 174 | 0.180 |
Why?
|
Genes, Modifier | 2 | 2017 | 5 | 0.180 |
Why?
|
Immunity, Innate | 1 | 2024 | 429 | 0.180 |
Why?
|
Muscle Contraction | 1 | 2021 | 284 | 0.180 |
Why?
|
Cell Movement | 1 | 2024 | 783 | 0.180 |
Why?
|
Chicago | 2 | 2021 | 1424 | 0.170 |
Why?
|
Lysosomes | 2 | 2010 | 111 | 0.170 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 1 | 2020 | 374 | 0.170 |
Why?
|
Myotonic Dystrophy | 1 | 2019 | 7 | 0.170 |
Why?
|
Transforming Growth Factor beta | 1 | 2021 | 321 | 0.170 |
Why?
|
MyoD Protein | 1 | 2019 | 16 | 0.170 |
Why?
|
Dual Specificity Phosphatase 6 | 1 | 2019 | 1 | 0.170 |
Why?
|
Point Mutation | 1 | 2019 | 245 | 0.160 |
Why?
|
Signal Transduction | 1 | 2009 | 3376 | 0.160 |
Why?
|
Severity of Illness Index | 1 | 2024 | 1838 | 0.160 |
Why?
|
Sarcoglycanopathies | 1 | 2018 | 2 | 0.160 |
Why?
|
Extracellular Signal-Regulated MAP Kinases | 1 | 2019 | 123 | 0.160 |
Why?
|
Morpholinos | 1 | 2018 | 13 | 0.160 |
Why?
|
Image Processing, Computer-Assisted | 1 | 2024 | 1240 | 0.160 |
Why?
|
Dystrophin | 4 | 2024 | 22 | 0.150 |
Why?
|
Adolescent | 2 | 2021 | 9247 | 0.150 |
Why?
|
Phenotype | 1 | 2024 | 2439 | 0.150 |
Why?
|
Osteopontin | 1 | 2017 | 47 | 0.150 |
Why?
|
Recombinant Proteins | 1 | 2019 | 1012 | 0.150 |
Why?
|
Protein Binding | 4 | 2022 | 1487 | 0.150 |
Why?
|
Phospholipids | 1 | 2017 | 112 | 0.140 |
Why?
|
Genetic Therapy | 2 | 2018 | 370 | 0.140 |
Why?
|
Sensitivity and Specificity | 1 | 2021 | 2014 | 0.140 |
Why?
|
Microscopy, Fluorescence | 2 | 2018 | 428 | 0.140 |
Why?
|
Exosomes | 1 | 2017 | 53 | 0.140 |
Why?
|
Cell Communication | 1 | 2017 | 199 | 0.130 |
Why?
|
Dystrophin-Associated Protein Complex | 1 | 2015 | 3 | 0.130 |
Why?
|
Electroporation | 1 | 2015 | 57 | 0.130 |
Why?
|
Transcription Factors | 1 | 2024 | 1652 | 0.130 |
Why?
|
Base Sequence | 1 | 2019 | 2327 | 0.130 |
Why?
|
Creatine Kinase | 1 | 2015 | 52 | 0.130 |
Why?
|
Oligonucleotides, Antisense | 1 | 2015 | 68 | 0.130 |
Why?
|
Luminescent Proteins | 1 | 2015 | 144 | 0.130 |
Why?
|
Plasmids | 1 | 2015 | 291 | 0.130 |
Why?
|
Microscopy, Confocal | 1 | 2015 | 277 | 0.120 |
Why?
|
Intracellular Space | 2 | 2014 | 38 | 0.120 |
Why?
|
Protein Engineering | 1 | 2015 | 141 | 0.120 |
Why?
|
Heterozygote | 1 | 2015 | 373 | 0.120 |
Why?
|
Genetic Predisposition to Disease | 2 | 2024 | 2338 | 0.120 |
Why?
|
Fluorescent Dyes | 1 | 2015 | 243 | 0.120 |
Why?
|
Cell Adhesion | 1 | 2015 | 426 | 0.120 |
Why?
|
Caveolin 3 | 1 | 2014 | 4 | 0.120 |
Why?
|
Cohort Studies | 1 | 2021 | 2866 | 0.120 |
Why?
|
Cell Line | 4 | 2024 | 2495 | 0.120 |
Why?
|
Polymerase Chain Reaction | 1 | 2016 | 922 | 0.110 |
Why?
|
HIV Infections | 1 | 2023 | 838 | 0.110 |
Why?
|
Aged | 2 | 2021 | 19128 | 0.110 |
Why?
|
Microscopy, Electron, Transmission | 1 | 2013 | 136 | 0.110 |
Why?
|
Intracellular Signaling Peptides and Proteins | 1 | 2015 | 387 | 0.110 |
Why?
|
Cell Survival | 1 | 2015 | 982 | 0.110 |
Why?
|
Endosomes | 2 | 2010 | 79 | 0.110 |
Why?
|
Cytoskeleton | 1 | 2014 | 195 | 0.100 |
Why?
|
MicroRNAs | 1 | 2017 | 551 | 0.100 |
Why?
|
Cytoplasmic Vesicles | 1 | 2010 | 5 | 0.090 |
Why?
|
Gene Expression Regulation | 3 | 2019 | 1975 | 0.090 |
Why?
|
Cardiotoxins | 1 | 2010 | 3 | 0.090 |
Why?
|
Lysosomal-Associated Membrane Protein 2 | 1 | 2009 | 4 | 0.090 |
Why?
|
Myoblasts, Skeletal | 1 | 2009 | 3 | 0.090 |
Why?
|
Myofibrils | 1 | 2009 | 23 | 0.090 |
Why?
|
Calcium Signaling | 1 | 2010 | 138 | 0.080 |
Why?
|
Models, Animal | 1 | 2010 | 276 | 0.080 |
Why?
|
Models, Biological | 1 | 2015 | 1765 | 0.080 |
Why?
|
Polymorphism, Single Nucleotide | 1 | 2016 | 2399 | 0.070 |
Why?
|
Endocytosis | 1 | 2008 | 180 | 0.070 |
Why?
|
RNA Splicing | 2 | 2019 | 152 | 0.070 |
Why?
|
Promoter Regions, Genetic | 1 | 2010 | 956 | 0.070 |
Why?
|
HEK293 Cells | 2 | 2022 | 639 | 0.070 |
Why?
|
Lamin Type A | 1 | 2006 | 26 | 0.070 |
Why?
|
Annexin A2 | 1 | 2024 | 2 | 0.060 |
Why?
|
Decorin | 1 | 2024 | 6 | 0.060 |
Why?
|
Electrophysiological Phenomena | 1 | 2024 | 51 | 0.060 |
Why?
|
Cell Nucleus | 1 | 2006 | 599 | 0.060 |
Why?
|
Blood Proteins | 1 | 2024 | 146 | 0.060 |
Why?
|
Bortezomib | 1 | 2024 | 82 | 0.060 |
Why?
|
Mutation | 3 | 2024 | 4141 | 0.060 |
Why?
|
Chromatin Immunoprecipitation | 1 | 2024 | 136 | 0.060 |
Why?
|
Arrhythmias, Cardiac | 1 | 2024 | 199 | 0.050 |
Why?
|
Quantitative Trait Loci | 2 | 2019 | 607 | 0.050 |
Why?
|
A549 Cells | 1 | 2022 | 41 | 0.050 |
Why?
|
Stress, Physiological | 1 | 2024 | 231 | 0.050 |
Why?
|
Nuclear Proteins | 1 | 2006 | 726 | 0.050 |
Why?
|
Vero Cells | 1 | 2022 | 102 | 0.050 |
Why?
|
Pilot Projects | 1 | 2024 | 868 | 0.050 |
Why?
|
Proteomics | 1 | 2023 | 230 | 0.050 |
Why?
|
Antibodies, Blocking | 1 | 2021 | 22 | 0.050 |
Why?
|
Immunoassay | 1 | 2021 | 91 | 0.050 |
Why?
|
Heart | 1 | 2024 | 573 | 0.050 |
Why?
|
HeLa Cells | 1 | 2022 | 511 | 0.050 |
Why?
|
Protein Structure, Tertiary | 2 | 2015 | 740 | 0.050 |
Why?
|
Anacardic Acids | 1 | 2019 | 1 | 0.040 |
Why?
|
Pulse Therapy, Drug | 1 | 2019 | 2 | 0.040 |
Why?
|
MEF2 Transcription Factors | 1 | 2019 | 9 | 0.040 |
Why?
|
T-Lymphocytes, Regulatory | 1 | 2023 | 306 | 0.040 |
Why?
|
Histone Acetyltransferases | 1 | 2019 | 42 | 0.040 |
Why?
|
Genetic Variation | 2 | 2019 | 1373 | 0.040 |
Why?
|
Residence Characteristics | 1 | 2021 | 202 | 0.040 |
Why?
|
Metabolomics | 1 | 2019 | 75 | 0.040 |
Why?
|
Kruppel-Like Transcription Factors | 1 | 2019 | 100 | 0.040 |
Why?
|
Disease Progression | 1 | 2023 | 1488 | 0.040 |
Why?
|
Epigenomics | 1 | 2019 | 103 | 0.040 |
Why?
|
Reading Frames | 1 | 2018 | 6 | 0.040 |
Why?
|
Primary Cell Culture | 1 | 2018 | 76 | 0.040 |
Why?
|
Survival Analysis | 1 | 2022 | 1534 | 0.040 |
Why?
|
Cellular Reprogramming | 1 | 2018 | 41 | 0.040 |
Why?
|
Annexin A1 | 1 | 2017 | 5 | 0.040 |
Why?
|
Urine | 1 | 2018 | 89 | 0.040 |
Why?
|
Transduction, Genetic | 1 | 2018 | 160 | 0.040 |
Why?
|
Drug Therapy, Combination | 1 | 2019 | 784 | 0.040 |
Why?
|
Receptors, Transforming Growth Factor beta | 1 | 2017 | 45 | 0.040 |
Why?
|
Mutation, Missense | 1 | 2019 | 277 | 0.040 |
Why?
|
Drug Evaluation, Preclinical | 1 | 2017 | 105 | 0.040 |
Why?
|
Muscular Atrophy | 1 | 2017 | 46 | 0.040 |
Why?
|
RNA-Binding Proteins | 1 | 2019 | 259 | 0.030 |
Why?
|
Transcriptional Activation | 1 | 2017 | 292 | 0.030 |
Why?
|
Recovery of Function | 1 | 2017 | 292 | 0.030 |
Why?
|
Receptors, Glucocorticoid | 1 | 2017 | 131 | 0.030 |
Why?
|
Chromosome Mapping | 1 | 2019 | 1076 | 0.030 |
Why?
|
Codon, Nonsense | 1 | 2015 | 44 | 0.030 |
Why?
|
Diaphragm | 1 | 2015 | 50 | 0.030 |
Why?
|
Epigenesis, Genetic | 1 | 2019 | 507 | 0.030 |
Why?
|
Drug Administration Schedule | 1 | 2017 | 895 | 0.030 |
Why?
|
Protein Interaction Mapping | 1 | 2015 | 82 | 0.030 |
Why?
|
Fibroblasts | 1 | 2018 | 755 | 0.030 |
Why?
|
Sequence Deletion | 1 | 2015 | 205 | 0.030 |
Why?
|
Reproducibility of Results | 1 | 2021 | 2754 | 0.030 |
Why?
|
Abdominal Muscles | 1 | 2014 | 19 | 0.030 |
Why?
|
Membranes | 1 | 2014 | 36 | 0.030 |
Why?
|
Cross-Sectional Studies | 1 | 2019 | 1710 | 0.030 |
Why?
|
Chromosomes, Mammalian | 1 | 2014 | 36 | 0.030 |
Why?
|
Recombinant Fusion Proteins | 1 | 2015 | 565 | 0.030 |
Why?
|
Organ Size | 1 | 2014 | 370 | 0.030 |
Why?
|
Disease Susceptibility | 1 | 2014 | 200 | 0.030 |
Why?
|
Alternative Splicing | 1 | 2014 | 210 | 0.030 |
Why?
|
Myocardium | 1 | 2015 | 571 | 0.030 |
Why?
|
Time Factors | 1 | 2021 | 5336 | 0.030 |
Why?
|
Drosophila melanogaster | 1 | 2015 | 613 | 0.020 |
Why?
|
Drosophila Proteins | 1 | 2015 | 508 | 0.020 |
Why?
|
RNA, Small Interfering | 1 | 2010 | 557 | 0.020 |
Why?
|
Heart Ventricles | 1 | 2014 | 779 | 0.020 |
Why?
|
Transferrin | 1 | 2008 | 19 | 0.020 |
Why?
|
Cell Fusion | 1 | 2008 | 39 | 0.020 |
Why?
|
Child | 1 | 2019 | 7158 | 0.020 |
Why?
|
Conserved Sequence | 1 | 2008 | 211 | 0.020 |
Why?
|
Sequence Alignment | 1 | 2008 | 353 | 0.020 |
Why?
|
Nuclear Envelope | 1 | 2006 | 38 | 0.020 |
Why?
|
Mutant Proteins | 1 | 2006 | 96 | 0.020 |
Why?
|
Hydroxyproline | 1 | 2005 | 11 | 0.020 |
Why?
|
Amino Acid Sequence | 1 | 2008 | 2062 | 0.010 |
Why?
|
Models, Molecular | 1 | 2008 | 1298 | 0.010 |
Why?
|
Molecular Sequence Data | 1 | 2008 | 3027 | 0.010 |
Why?
|
Motor Activity | 1 | 2005 | 327 | 0.010 |
Why?
|